BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
DoP Forms Committee to Reform Drug Pricing Framework March 13, 2024 The objective is to strike a balance between ensuring the availability of essential medicines and incentivizing the industry for sustainable growth and exports.
DoP Revises PTUAS Guidelines to Support MSMEs March 12, 2024 The Department of Pharmaceuticals (DoP) has made substantial changes to the Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS) sub-scheme, with a focus on aiding MSMEs in the pharmaceutical sector.
Parl Panel Urges DoP to Expedite Recruitment of Medical Devices Officers March 4, 2024 The Department-related Parliamentary Standing Committee on Chemicals and Fertilizers has called upon the Department of Pharmaceuticals (DoP) to ensure the timely recruitment of officers to regulate the medical devices sector.
Parl Panel Urges DoP to Include Medical Devices in NLEM February 19, 2024 The Parliamentary Panel has recommended the Department of Pharmaceuticals (DoP) to include medium and high-end medical devices essential for critical care into the National List of Essential Medicines (NLEM).
Parl Panel Demands Increased Funding Outlay for Key Pharma Initiatives January 3, 2024 The Committee restated its prior recommendation, highlighting that the absence of funds for new schemes would negatively affect the development and expansion of the NIPER scheme.
Medical Devices PLI Scheme Records INR 879 Cr+ Investments till Sep 2023 January 2, 2024 Launched in July 2020, the PLI scheme seeks to bridge the manufacturing gap in medical devices within the country compared to other economies.
PMBJP Records INR 935.25 Cr Worth Sales till Nov 2023 December 21, 2023 The impact of PMBJP is evident in the savings it offers to the public. In November 2023, consumers saved approximately INR 611.85 Cr by purchasing medicines from PMBJP Kendras instead of other retailers.
Draft NPP Calls for Streamlining Digital Healthcare & Reducing Environmental Impact November 9, 2023 The policy embraces digital technologies, including telemedicine, EHRs, and data analytics for healthcare and pharmaceutical innovation, using AI, machine learning, and blockchain.
DoP Eyeing Stable & Cost-Effective Supply Chain Through International Collaboration November 6, 2023 As per the draft policy, the DoP seeks to boost the global standing of the Indian pharmaceutical industry through international collaborations for decentralised manufacturing and government-to-government drug distribution initiatives.
Dept of Pharmaceuticals Releases Draft National Pharmaceuticals Policy, 2023 November 2, 2023 The NPP primarily aims to shape the pharmaceutical industry, addressing investments, technology access, research, development, and regulations. It establishes quantifiable goals in line with the government's Amrit Kaal Vision@2047.
